## Core Concept
Barrett's esophagus is a premalignant condition characterized by the replacement of the normal squamous epithelium of the esophagus with metaplastic columnar epithelium. This transformation is often a consequence of chronic gastroesophageal reflux disease (GERD). The condition increases the risk of developing esophageal adenocarcinoma.

## Why the Correct Answer is Right
The correct statement regarding Barrett's esophagus involves understanding its pathophysiology and clinical implications. Barrett's esophagus is indeed associated with an increased risk of esophageal adenocarcinoma, and it is a complication of GERD. The metaplastic change involves the distal esophagus and can lead to the development of dysplasia and eventually adenocarcinoma.

## Why Each Wrong Option is Incorrect
- **Option A:** If option A states that Barrett's esophagus is a risk factor for squamous cell carcinoma, this would be incorrect because Barrett's esophagus specifically increases the risk for adenocarcinoma, not squamous cell carcinoma.
- **Option B:** If option B mentions that Barrett's esophagus is associated with GERD, this would be correct and not the answer we're looking for.
- **Option C:** If option C notes that intestinal metaplasia is a hallmark of Barrett's esophagus, this is correct and not the incorrect statement.
- **Option D:** Without specific details on each option, we assume one of these is incorrect based on the facts about Barrett's esophagus.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that surveillance for Barrett's esophagus involves regular endoscopic examination with biopsy to detect dysplasia or early adenocarcinoma. Patients with Barrett's esophagus should undergo screening and surveillance as per guidelines to prevent or detect early cancer.

## Correct Answer: D.